Increased yield of porcine circovirus-2 by a combined treatment of PK-15 cells with interferon-gamma and inhibitors of endosomallysosomal system acidification

dc.contributor.authorMisinzo, G.
dc.contributor.authorDelputte, P. L.
dc.contributor.authorLefebvre, D. J.
dc.contributor.authorNauwynck, H. J.
dc.date.accessioned2017-06-23T06:28:22Z
dc.date.available2017-06-23T06:28:22Z
dc.date.issued2007-12-17
dc.descriptionArchives virology 2008, Vol. 153: 337–342en_US
dc.description.abstractTreatment of porcine kidney (PK-15) cells with either interferon-gamma (IFN-g) or endosomallysosomal system acidification inhibitors increases replication of porcine circovirus type 2 (PCV2). In the present study, the effect of a combination of these treatments on the number of infected cells and virus yield was tested. The number of PCV2 (Stoon-1010)-infected PK-15 cells increased in cells treated with ammonium chloride (445 39% increase), IFN-g (446 8%), ammonium chlorideþ IFN-g (1721 283%), chloroquine diphosphate (1037 121%), chloroquine diphosphateþIFN-g (2199 255%), monensin (950 178%) and monensinþIFN-g (1948 60%). Combined IFNg and endosomal-lysosomal system acidification inhibitors increased PCV2 yield by up to 50 times compared to untreated PK-15. This augmented virus replication in PK-15 cells may be helpful in the production of PCV2 vaccines.en_US
dc.identifier.urihttps://www.suaire.sua.ac.tz/handle/123456789/1671
dc.language.isoenen_US
dc.subjectPorcine circovirus-2en_US
dc.subjectPK-15 cellsen_US
dc.subjectEndosomallysosomal systemen_US
dc.subjectInterferon-gamma (IFN-g)en_US
dc.titleIncreased yield of porcine circovirus-2 by a combined treatment of PK-15 cells with interferon-gamma and inhibitors of endosomallysosomal system acidificationen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
misinzo 8.pdf
Size:
149.12 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.66 KB
Format:
Item-specific license agreed upon to submission
Description: